The Current Status of Time Dependent CYP Inhibition Assay and In Silico Drug-drug Interaction Predictions

E-ISSN： 1873-4294|12|11|1291-1297

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.11, 2012-06, pp. : 1291-1297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Silico Predictions and In Vivo Results of Drug–Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 364-373

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically based pharmacokinetic modeling to predict complex drug–drug interactions: a case study of AZD2327 and its metabolite, competitive and time‐dependent CYP3A inhibitors

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 8, 2015-11 ,pp. : 507-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-Drug Interaction Prediction Assessment

By Zhou Jihao

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 4, 2009-07 ,pp. : 641-657

Taylor & Francis Ltd

Access to resources Recommend Favorite

Drug-Drug Interaction Pattern Recognition

By Duan John Z.

Drugs in R&D, Vol. 10, Iss. 1, 2010-05 ,pp. : 9-24

Adis International

Access to resources Recommend Favorite

In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development: Current Status and Future Directions

By Pelkonen Olavi

Clinical Pharmacokinetics, Vol. 50, Iss. 8, 2011-08 ,pp. : 483-491

Adis International

Access to resources Recommend Favorite